Dynavax Technologies Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
DVAX Nasdaq 8731 https://www.dynavax.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Dynavax Technologies Corp

Dynavax Technologies Corporation (NASDAQ:DVAX) Could Be Riskier Than It Looks - Mar 19th, 2023 12:56 pm
Dynavax to Present at the Cowen 43rd Annual Health Care Conference - Mar 1st, 2023 9:15 pm
Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine - Feb 28th, 2023 1:00 pm
Need To Know: Analysts Just Made A Substantial Cut To Their Dynavax Technologies Corporation (NASDAQ:DVAX) Estimates - Feb 26th, 2023 12:30 pm
Here Are 3 Healthcare Stocks That Deliver - Feb 24th, 2023 6:00 pm
Q4 2022 Dynavax Technologies Corp Earnings Call - Feb 24th, 2023 2:24 pm
Dynavax Technologies (DVAX) Q4 2022 Earnings Call Transcript - Feb 24th, 2023 1:00 am
Dynavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Financial Guidance - Feb 23rd, 2023 9:05 pm
13 High Growth Pharma Stocks that are Profitable - Feb 23rd, 2023 3:50 pm
Dynavax Technologies Corporation's (NASDAQ:DVAX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Feb 17th, 2023 3:01 pm
Wall Street Analysts See a 109.61% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High? - Feb 16th, 2023 2:55 pm
Blueprint's (BPMC) Cancer Study Put on Partial Hold by FDA - Feb 13th, 2023 4:53 pm
Do Options Traders Know Something About Dynavax Technologies (DVAX) Stock We Don't? - Feb 10th, 2023 1:34 pm
Dynavax to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 23, 2023 - Feb 9th, 2023 9:15 pm
Dynavax Technologies (DVAX) Upgraded to Strong Buy: Here's What You Should Know - Feb 8th, 2023 5:00 pm
Dynavax Announces Uplisting to the Nasdaq Global Select Market - Jan 31st, 2023 9:15 pm
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 103.22%: Read This Before Placing a Bet - Jan 26th, 2023 2:55 pm
Clover Provides Updates on COVID-19 Vaccine Commercial Launch and Strategic Priorities in 2023 - Jan 16th, 2023 12:00 am
The 7 Most Undervalued Long-Term Stocks to Buy in January - Jan 14th, 2023 9:03 pm
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Highlights and Phase 1 Shingles Topline Results - Jan 9th, 2023 1:00 pm